<p>(<b>A</b>) Quantification of IFNα in the supernatants of PBMCs, pDC-depleted PBMCs and isolated pDCs (Responders) co-cultured with DENV infected Huh7.5.1 cells (DENV cells) or treated with 100 µl of supernatants from the latter (DENV SN), as indicated (Inducers). Viral titers of DENV SN ≈2.5×10<sup>6</sup> foci forming units (ffu)/ml. pDC depletion/enrichment was performed using an anti-BDCA-4 antibody. Cell #; number of co-cultured responder cells. Cont cells; uninfected Huh-7.5.1 cells. Arrows indicate results below the detection threshold of the IFNα ELISA (<i>i.e.</i>, 12.5 pg/ml). Results are representative of 4 independent experiments. Error bars represent the means ± SD. (<b>B</b>) Representative FACS analysis of pDC depletion and...
<p>PBMCs from healthy donors were stimulated overnight with DENV-2, mock or none (unstimulated). (<b...
<p><b>A</b>. Flow cytometry analysis of the expression of plasmacytoid or myeloid DC markers in IFN-...
<p>(A) 293T cells stably expressing non-targeting shRNA (shControl) or shRNA against UBR4 (shUBR4 #2...
<p>(<b>A–B</b>) Quantification of IFNα in supernatants of pDCs co-cultured with infected monocyte-de...
<p>(<b>A</b>) Quantification of IFNα in the supernatants of PBMCs and pDCs isolated from two differe...
<p>The impact of mutations in NS5 (Rep<sup>−/−</sup>, substitutions G81A, G83A and G85A), capsid (ΔV...
<p>(<b>A</b>) DENV RNA is transferred from infected cells to pDCs. Upper panels, projections of conf...
A. Representative FACS analysis of pDC isolation and depletion from PBMCs using the CD123 and BDCA-2...
<p>Several cell populations (pDCs, B cells, cDCs, Monocytes and MDDCs) were isolated from human bloo...
<p>(<b>A–E</b>) The impact of mutations in prM (substitutions R88A, K90A and R91A) on the levels of ...
<p>(<b>A</b>) IFN-competent A549 cells were treated with 100 IU/ml IFN-α prior to (-4 h, -2 h) or af...
<p><b>(A-C)</b> Control (MT4-shNT) or BST2-depleted (MT4-shBST2) MT4 cells were mock-infected, or in...
<p><b>A)</b> PBMCs or purified B cells were mock-treated or cultured with DENV2. After 12 days p.i.,...
<p>(A) Murine pDCs and cDCs were purified from Flt3L-BMDCs using FACS. 2×10<sup>5</sup> pDCs (CD11c<...
<p>(<b>A</b>, <b>B</b> and <b>D</b>) hPBMCs collected from the blood of healthy donors were distribu...
<p>PBMCs from healthy donors were stimulated overnight with DENV-2, mock or none (unstimulated). (<b...
<p><b>A</b>. Flow cytometry analysis of the expression of plasmacytoid or myeloid DC markers in IFN-...
<p>(A) 293T cells stably expressing non-targeting shRNA (shControl) or shRNA against UBR4 (shUBR4 #2...
<p>(<b>A–B</b>) Quantification of IFNα in supernatants of pDCs co-cultured with infected monocyte-de...
<p>(<b>A</b>) Quantification of IFNα in the supernatants of PBMCs and pDCs isolated from two differe...
<p>The impact of mutations in NS5 (Rep<sup>−/−</sup>, substitutions G81A, G83A and G85A), capsid (ΔV...
<p>(<b>A</b>) DENV RNA is transferred from infected cells to pDCs. Upper panels, projections of conf...
A. Representative FACS analysis of pDC isolation and depletion from PBMCs using the CD123 and BDCA-2...
<p>Several cell populations (pDCs, B cells, cDCs, Monocytes and MDDCs) were isolated from human bloo...
<p>(<b>A–E</b>) The impact of mutations in prM (substitutions R88A, K90A and R91A) on the levels of ...
<p>(<b>A</b>) IFN-competent A549 cells were treated with 100 IU/ml IFN-α prior to (-4 h, -2 h) or af...
<p><b>(A-C)</b> Control (MT4-shNT) or BST2-depleted (MT4-shBST2) MT4 cells were mock-infected, or in...
<p><b>A)</b> PBMCs or purified B cells were mock-treated or cultured with DENV2. After 12 days p.i.,...
<p>(A) Murine pDCs and cDCs were purified from Flt3L-BMDCs using FACS. 2×10<sup>5</sup> pDCs (CD11c<...
<p>(<b>A</b>, <b>B</b> and <b>D</b>) hPBMCs collected from the blood of healthy donors were distribu...
<p>PBMCs from healthy donors were stimulated overnight with DENV-2, mock or none (unstimulated). (<b...
<p><b>A</b>. Flow cytometry analysis of the expression of plasmacytoid or myeloid DC markers in IFN-...
<p>(A) 293T cells stably expressing non-targeting shRNA (shControl) or shRNA against UBR4 (shUBR4 #2...